http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CA-2628747-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a73cee5001ad08339ae751c10d9abf71
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-496
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P5-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-565
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-496
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-565
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P5-00
filingDate 2006-11-21-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4fb320c3793708cafebb1a0bf63c959c
publicationDate 2007-05-31-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CA-2628747-A1
titleOfInvention Combinations of hormone therapy agents and metalloprotease inhibitors for the treatment of cancer
abstract The present invention provides methods of treating cancer comprising treating a patient in need thereof with hormone therapy and administering to the patient a therapeutically effective amount of at least one metalloprotease inhibitor. The present invention also provides pharmaceutical compositions comprising a therapeutically effective amount of at least one hormone therapy agent, at least one metalloprotease inhibitor, and a pharmaceutically acceptable carrier.
priorityDate 2005-11-22-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID24890
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID542448
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID455581532
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID403640
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID407238
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458396411
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID463079
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457584123
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID13982
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419592309
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458394811
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID443228
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID837856
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415810339
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID397435
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458397365
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID567365
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419560844
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID396099
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID259252
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID16129706
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID100534514
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457444288
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID100037781
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID104741
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID36523
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID16070111
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID100304474
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID2099
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID852433
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393622
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID100136026
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419590756

Total number of triples: 53.